Leerink Partnrs Issues Positive Estimate for KPTI Earnings
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Free Report) – Research analysts at Leerink Partnrs boosted their Q2 2025 earnings estimates for Karyopharm Therapeutics in a research note issued to investors on Monday, May 12th. Leerink Partnrs analyst J. Chang now forecasts that the company will earn ($3.47) per share for the quarter, up from their previous […]
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Free Report) – Research analysts at Leerink Partnrs boosted their Q2 2025 earnings estimates for Karyopharm Therapeutics in a research note issued to investors on Monday, May 12th. Leerink Partnrs analyst J. Chang now forecasts that the company will earn ($3.47) per share for the quarter, up from their previous […]
